Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)
Clinical trial NCT02720081 · COMPLETED
Trial details
- NCT number
- NCT02720081
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-11
- Primary completion
- 2017-08-16
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.